Overview

Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This study will examine the safety, tolerability and efficacy of NVXT in a new formulation in patients with mild-to-moderate fungal infection of the toe nail.
Phase:
Phase 2
Details
Lead Sponsor:
Taro Pharmaceuticals USA
Treatments:
Pharmaceutical Solutions